Presbyopia IOL Panel Probes Concerns About Trial Sponsor Burdens
This article was originally published in The Gray Sheet
Executive Summary
Clinical trials of clear lens extraction (CLE) to treat presbyopia should strive for uncorrected distance visual acuity of 20/25 or 20/30 in 90%-95% of patients, members of FDA's Ophthalmic Devices Panel suggested at a March 5 meeting in Gaithersburg, Md
You may also be interested in...
CrystaLens Accommodating IOL First To Market; Firm Eyes Expanded Labeling
Eyeonics, Inc. will file a supplemental PMA for its CrystaLens AT-45 accommodating posterior chamber intraocular lens to broaden the treatment range beyond 1.0 diopter
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.